Roads to Recovery


Invesco’s Kevin Holt, Devin Armstrong and Matt Seinsheimer describe why they can be agnostic about business quality, how their own compensation supports their strategy, how they handle the misery of investing too early, and why they see mispriced value in Weatherford, Royal Dutch Shell, Allstate, Bank of New York Mellon and Citigroup.

If you are a subscriber, log in to access the issue and bonus archive: